ATTMOS Inc.

ATTMOS Inc. is a privately held American scientific software company headquartered in Lansing, Michigan, and founded in 2022 by a group of academics from Michigan State University, Rutgers University, and UC San Diego. The company develops research-grade computational platforms, custom scientific workflows, and high-performance computing (HPC) infrastructure aimed at drug discovery, computational chemistry, and molecular modeling. Its stated mission is to bring novel technologies into the drug discovery process and to make advanced computational tools affordable and accessible to research teams that have historically lacked the resources of large pharmaceutical companies. ATTMOS positions itself at the intersection of academia and industry. Its founding team brings more than 25 years of combined expertise in drug discovery, computational chemistry, and scientific software engineering, and the company has received support from an NIH Fast-Track SBIR award to advance its initial software products. The company's offerings span three main areas: scientific software (computational platforms and bespoke tools for molecular modeling, simulation, and data analysis), custom scientific workflows and automation pipelines, and infrastructure and HPC services. Its VCM platform orchestrates CPU and GPU workloads across in-house HPC clusters, public cloud, and community resources, and the company also provides hardware procurement, cluster deployment, and integration support. In addition to software, ATTMOS conducts contract research and consulting in computational drug discovery, collaborating with pharmaceutical, biotech, and academic groups on force-field development, pose refinement, and free-energy workflows. Leadership includes cofounder Madu Manathunga, PhD, who serves as President and CEO and is a computational chemist and scientific software engineer with expertise in quantum chemistry, free energy methods, and high-performance computing, and Darrin York, PhD, who serves as Chief Scientific Advisor and is a leader in theoretical and computational chemistry. The company remains private and continues to develop and expand its software and research services.

ATTMOS Inc. was founded in 2022 by a diverse team of academics with deep expertise in drug discovery, computational chemistry, high-performance computing, and scientific software. The founding group came from Michigan State University, Rutgers University, and UC San Diego, bringing more than 25 years of combined expertise in drug discovery, computational chemistry, and scientific software engineering. The company is headquartered in Lansing, Michigan, United States. From its inception, ATTMOS focused on building advanced computational platforms for molecular modeling and drug discovery. Its work has been supported by an NIH Fast-Track SBIR award, which helped advance its initial software products and continued growth. The company's mission is to bring novel technologies into the drug discovery process and make advanced computational tools affordable and accessible to research teams everywhere, reducing the cost barrier to tools once limited to large pharmaceutical companies. ATTMOS develops scientific software, research platforms, and computational workflows that help teams move from complex ideas to practical results. Its offerings include research-grade computational platforms and bespoke tools for molecular modeling, simulation, and data analysis; custom scientific workflows and automation pipelines; and infrastructure and HPC services. Its VCM platform orchestrates CPU and GPU workloads across in-house HPC clusters, public cloud, and community resources, and the company provides hardware procurement, cluster deployment, and integration support for teams scaling their compute stack. In addition to software, ATTMOS conducts contract research and consulting on computational drug discovery, collaborating with pharmaceutical, biotech, and academic groups across force-field development, pose refinement, and free-energy workflows. Leadership includes cofounder Madu Manathunga, PhD, as President and CEO, and Darrin York, PhD, as Chief Scientific Advisor. The company remains private and continues to develop and expand its software and research services.

• 2022

  ATTMOS Inc. founded by academics from Michigan State University, Rutgers University, and UC San Diego.

• Received NIH Fast-Track SBIR award to advance initial software products and growth.

Affordable, accessible, and practical advanced computational tools for drug discovery, bridging academia and industry.

• VCM

  HPC orchestration platform that manages CPU and GPU workloads across in-house HPC clusters, public cloud, and community resources.

• Scientific Software Platforms

  Research-grade computational platforms and bespoke tools for molecular modeling, simulation, and data analysis.

• Custom Scientific Workflows

  Custom scientific workflows and automation pipelines built to specific project requirements.

• Infrastructure & HPC Services

  Hardware procurement, cluster deployment, and integration support for teams scaling their compute stack.

• Drug Discovery Research Services

  Contract research and consulting on computational drug discovery, including force-field development, pose refinement, and free-energy workflows.

1. 1ATTMOS Inc. | Scientific Software for Drug Discoveryattmosdiscovery.com
2. 2About ATTMOS | ATTMOS Inc.attmosdiscovery.com
3. 3ATTMOS Inc. (United States) - Wikidatawikidata.org